PACB · Pacific Biosciences Of California, Inc. · Executive Compensation
$1.86
-0.10 (-5.09%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$613.34M
Shares
312.93M
Volume · Nov 16
4.92M
Avg daily vol (3M)
12.42M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Christian O. Henry | President and Chief Executive Officer | $4,309,846 |
| Jim R. Gibson | Chief Financial Officer | $3,493,189 |
| Mark Van Oene | Chief Operating Officer | $2,366,113 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Christian O. Henry | President and Chief Executive Officer | $9,181,620 |
| Mark Van Oene | Chief Operating Officer | $4,805,004 |
| Jeff Eidel | Former Chief Commercial Officer | $3,333,167 |
| Susan G. Kim | Former Chief Financial Officer | $2,669,453 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Christian O. Henry | President and Chief Executive Officer | $8,046,575 |
| Mark Van Oene | Chief Operating Officer | $4,601,322 |
| Jeff Eidel | Former Chief Commercial Officer | $2,533,727 |
| Susan G. Kim | Former Chief Financial Officer | $2,519,275 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Christian O. Henry | President and Chief Executive Officer | $6,616,251 |
| Mark Van Oene | Chief Operating Officer | $6,563,691 |
| Jeff Eidel | Former Chief Commercial Officer | $5,801,485 |
| Susan G. Kim | Former Chief Financial Officer | $2,618,112 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mark Van Oene | Chief Operating Officer | $28,299,433 |
| Christian O. Henry | President, Chief Executive Officer | $2,866,931 |
| Susan G. Kim | Chief Financial Officer | $1,279,672 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Bill Meyer | Chief Accounting Officer | Appointed | 2026-11-04 |
| Mark Van Oene | interim Chief Financial Officer | Appointed | 2026-11-04 |
| Christian O. Henry | President and Chief Executive Officer | Resigned | 2026-08-05 |
| Mark Van Oene | member of the Board | Appointed | 2026-08-05 |
| Mark Van Oene | President and Chief Executive Officer | Appointed | 2026-08-05 |
|
Christopher M. Smith
“The Company is not aware of any disagreement between Mr. Smith and the Company on any matter relating to the Company’s operations, policies or practices that resulted in Mr. Smith’s resignation.”
|
member of the board of directors | Resigned | 2026-07-09 |
| John F. Milligan, Ph.D. | Class III Director | Appointed | 2026-06-04 |
| Christian O. Henry | Class III Director | Appointed | 2026-06-04 |
| Chris Gibson, Ph.D. | Class III Director | Appointed | 2026-06-04 |
| Christopher M. Smith | Class III Director | Appointed | 2026-06-04 |
| Kathy Ordoñez | Class III Director | Appointed | 2026-06-04 |
| William Ericson | Class III Director |
Already on the board
Since at least 2004: re-election or new board role
|
2026-06-04 |
| Michele Farmer | Chief Accounting Officer | Resigned | 2026-03-06 |
| Christopher Gibson, Ph.D. | member of the Company's Science and Technology Committee | Appointed | 2026-03-05 |
| Christopher Gibson, Ph.D. | Class I director | Appointed | 2026-03-05 |
| Christopher M. Smith | Class III Director | Appointed | 2025-06-06 |
| Kathy Ordoñez | Class III Director | Appointed | 2025-06-06 |
| William Ericson | Class III Director |
Already on the board
Since at least 2004: re-election or new board role
|
2025-06-06 |
| Jim R. Gibson | Chief Financial Officer | Appointed | 2025-03-27 |
| David Meline | member of the Board | Resigned | 2025-01-30 |
| Christopher M. Smith | Class III director | Appointed | 2025-01-30 |
| Susan G. Kim | Chief Financial Officer and principal financial officer | Resigned | 2024-12-06 |
| Christian Henry | interim Chief Financial Officer | Appointed | 2024-12-06 |
| Jeff Eidel | Chief Commercial Officer | Terminated | 2024-11-12 |
| Susan Kim | Chief Financial Officer | Resigned | 2024-11-07 |
Leadership
- Christian Henry CEO, CFO, Board Member
- Mark Van Oene CEO, CFO, COO, Board Member
- Christian O. Henry Chairman, Board Member
- John F. Milligan Chairman, Board Member
- Ben Gong CFO
- Jim R. Gibson CFO
- Eric E. Schaefer Chief Accounting Officer
- Chris Gibson Board Member
- Chris Gibson, Ph.D. Board Member
- Christopher Gibson, Ph.D. Board Member
- Christopher M. Smith Board Member
- David Meline Board Member
- Hannah A. Valantine Board Member
- Hannah A. Valantine, M.D. Board Member
- John F. Milligan, Ph.D. Board Member
- Kathy Ordoñez Board Member
- Marshall Mohr Board Member
- Randy Livingston Board Member
- William Ericson Board Member
Key facts
CIK
1299130
CUSIP
69404D108
13F (30d)
158 filings
139 filers
Visit website
Investor relations